RNA解旋酶A
细胞生物学
新生内膜
血管平滑肌
解旋酶
核糖核酸
生物
死盒子
转录因子
分子生物学
医学
基因
内科学
内分泌学
遗传学
再狭窄
平滑肌
支架
作者
Ye Fan,Yikuan Chen,Jing Zhang,Feng Yang,Yanhua Hu,Li Zhang,Chunyu Zeng,Qingbo Xu
标识
DOI:10.1161/circresaha.119.314062
摘要
Rationale: RNA helicases, highly conserved enzymes, are currently believed to be not only involved in RNA modulation, but also in other biological processes. We recently reported that RNA helicase DDX (DEAD-box protein)-5 is required for maintaining the homeostasis of vascular smooth muscle cells (SMCs). However, the expression and function of RNA helicase in vascular physiology and disease is unknown. Objective: To investigate the role of RNA helicase in vascular diseases. Methods and Results: We showed here that DDX-5 was the most abundant DEAD-box protein expressed in human and rodent artery, which mainly located in SMCs. It was demonstrated that DDX-5 levels were reduced in cytokine-stimulated SMCs and vascular lesions. DDX-5 knocking down or deficiency increased SMC proliferation and migration, whereas overexpression of DDX-5 prevented aberrant proliferation and migration of SMCs. Mechanistic studies revealed transcription factor GATA (GATA-binding protein)-6 as a novel downstream target of DDX-5, which directly interacted with GATA-6 and protected it from MDM (mouse double minute)-2–mediated degradation. Our ChIP assay identified a previously unreported binding of p27 Kip1 promoter to GATA-6. DDX-5 increased the recruitment of GATA-6 to p27 Kip1 promoter, which enhanced p27 Kip1 expression and maintained SMC quiescence. Finally, we showed exacerbated neointima formation in DDX-5 SMC-deficient mice after femoral artery injury, whereas overexpression of DDX-5 potently inhibited vascular remodeling in balloon-injured rat carotid artery. Conclusions: These findings provide the first evidence for a role of RNA helicase DDX-5 in the protection against SMC proliferation, migration, and neointimal hyperplasia. Our data extend the fundamental role of RNA helicase beyond RNA modulation, which provides the basic information for new therapeutic strategies for vascular diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI